-
Contains�9�relevant, practice-oriented topics�including�atherosclerotic cardiovascular risk stratification in the rheumatic diseases; subclinical atherosclerosis evaluation across various vascular territories; lessons from heart and large vessel biopsies in patients with and without autoimmune rheumatic disease; the�role of lipoprotein levels and function in atherosclerosis associated with autoimmune rheumatic diseases;�and more.�
-
Provides in-depth�clinical reviews on�cardiovascular complications of chronic rheumatic diseases,�offering�actionable insights for clinical practice.�
-
Presents the�latest information on this timely, focused topic�under the leadership of experienced editors in the field.�Authors synthesize and distill the latest research and practice guidelines to create�clinically significant,�topic-based reviews.�
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Time Trends of Cardiovascular Disease in the General Population and Inflammatory ArthritisAtherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases: An Integrative, Multiparametric Approach
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases
Heart Failure in Rheumatic Disease: Secular Trends and Novel Insights
Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies
Venous Thromboembolism in the Inflammatory Rheumatic Diseases
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?
